Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial - von Minckwitz, G; Kummel, S; Vogel, P (J Natl Cancer Inst, 2008)